Read More Pharma Industry News New hope for asthma and eczema? Akeso’s latest antibody AK139 enters clinical trials Akeso, Inc. (9926.HK) has announced a major milestone with the acceptance of its Investigational New Drug (IND) application… byPallavi MadhirajuFebruary 14, 2025